QIAGEN is the world’s leading provider of innovative Sample & Assay Technologies, and a key player in the molecular biology revolution. More than one-half million customers throughout the world rely on the company’s products. QIAGEN’s sample technologies help to isolate genetic material and other molecules from biological samples such as blood, bone and tissue. These can then be analyzed using appropriate assay technologies to reveal the information concealed within. QIAGEN’s products transform raw bio- logical material into valuable molecular information according to standardized and reproducible procedures.

Research Grants 28 show all


$6.3M
2011

$16.8M
2014

$8.8M
2015

$2.1M
2017

$26.2M
2019

Patents 2,133show all

  • 615
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 557
    C12N - Microorganisms or enzymes
  • 310
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 193
    B01L - Chemical or physical laboratory apparatus for general use
  • 83
    B01D - Separation
  • 62
    C07K - Peptides
  • 54
    C07H - Sugars
  • 50
    B01J - Chemical or physical processes, e.g. catalysis or colloid chemistry
  • 36
    C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture
  • 27
    B03C - Magnetic or electrostatic separation of solid materials from solid materials or fluids

Clinical Trials 6show all

SEC Filings show all


1
D

Contact Information

Valencia, CA
United States

SEC Form D Funding Events

DateOfferedSoldType
2002-04-30Unknown Unknown Other (Paper Filing)